Zotarolimus-eluting stent-induced hypersensitivity pneumonitis.

Suppr

超能文献

作者信息

Shin Hong-Won, Nam Chang-Wook, Kim Hyungseop, Hur Seung-Ho, Kim Yoon-Nyun, Kim Kwon-Bae, Kwon Kun-Young

出版信息

Korean J Intern Med. 2013 Jan;28(1):108-11. doi: 10.3904/kjim.2013.28.1.108. Epub 2012 Dec 28.

DOI:10.3904/kjim.2013.28.1.108

PMID:23346006

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3543950/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e3a/3543950/d90131d9a397/kjim-28-108-g001.jpg

相似文献

Zotarolimus-eluting stent-induced hypersensitivity pneumonitis.

Korean J Intern Med. 2013 Jan;28(1):108-11. doi: 10.3904/kjim.2013.28.1.108. Epub 2012 Dec 28.

Differential clinical outcomes after 1 year versus 5 years in a randomised comparison of zotarolimus-eluting and sirolimus-eluting coronary stents (the SORT OUT III study): a multicentre, open-label, randomised superiority trial.

Lancet. 2014 Jun 14;383(9934):2047-2056. doi: 10.1016/S0140-6736(14)60405-0. Epub 2014 Mar 14.

Five-year clinical outcomes in patients with diabetes mellitus treated with polymer-free sirolimus- and probucol-eluting stents versus second-generation zotarolimus-eluting stents: a subgroup analysis of a randomized controlled trial.

Cardiovasc Diabetol. 2016 Sep 1;15(1):124. doi: 10.1186/s12933-016-0429-y.

Randomized Trial of Polymer-Free Sirolimus- and Probucol-Eluting Stents Versus Durable Polymer Zotarolimus-Eluting Stents: 5-Year Results of the ISAR-TEST-5 Trial.

JACC Cardiovasc Interv. 2016 Apr 25;9(8):784-792. doi: 10.1016/j.jcin.2016.01.009. Epub 2016 Mar 23.

Five-year follow-up of polymer-free sirolimus- and probucol-eluting stents versus new generation zotarolimus-eluting stents in patients presenting with st-elevation myocardial infarction.

Catheter Cardiovasc Interv. 2017 Feb 15;89(3):367-374. doi: 10.1002/ccd.26597. Epub 2016 Jul 5.

Comparison of Durable-Polymer Zotarolimus-Eluting and Biodegradable-Polymer Biolimus-Eluting Coronary Stents in Patients With Coronary Artery Disease: 3-Year Clinical Outcomes in the Randomized SORT OUT VI Trial.

JACC Cardiovasc Interv. 2017 Feb 13;10(3):255-264. doi: 10.1016/j.jcin.2016.11.007. Epub 2017 Jan 18.

The OCT-ORION Study: A Randomized Optical Coherence Tomography Study Comparing Resolute Integrity to Biomatrix Drug-Eluting Stent on the Degree of Early Stent Healing and Late Lumen Loss.

Circ Cardiovasc Interv. 2018 Apr;11(4):e006034. doi: 10.1161/CIRCINTERVENTIONS.117.006034.

Efficacy and safety of zotarolimus-eluting stents compared with sirolimus-eluting stents in patients undergoing percutaneous coronary interventions--a meta-analysis of randomized controlled trials.

Int J Cardiol. 2013 Sep 1;167(5):2126-33. doi: 10.1016/j.ijcard.2012.05.105. Epub 2012 Jun 15.

Very thin strut biodegradable polymer everolimus-eluting and sirolimus-eluting stents versus durable polymer zotarolimus-eluting stents in allcomers with coronary artery disease (BIO-RESORT): a three-arm, randomised, non-inferiority trial.

Lancet. 2016 Nov 26;388(10060):2607-2617. doi: 10.1016/S0140-6736(16)31920-1. Epub 2016 Oct 30.

Incidence of late-acquired stent malapposition of drug eluting stents with second generation permanent and biodegradable polymer coatings-A prospective, randomized comparison using optical coherence tomography.

J Interv Cardiol. 2018 Dec;31(6):780-791. doi: 10.1111/joic.12572. Epub 2018 Nov 27.

引用本文的文献

Coronary stent implantation links to the occurrence of eosinophilia and interstitial pneumonia: a case report and systematic review.

BMC Pulm Med. 2024 Jun 17;24(1):281. doi: 10.1186/s12890-024-03101-x.

Hypersensitivity and in-stent restenosis in coronary stent materials.

Front Bioeng Biotechnol. 2022 Sep 15;10:1003322. doi: 10.3389/fbioe.2022.1003322. eCollection 2022.

Drug Eluting Stents for Malignant Airway Obstruction: A Critical Review of the Literature.

J Cancer. 2016 Jan 13;7(4):377-90. doi: 10.7150/jca.13611. eCollection 2016.

Learning from the Cardiologists and Developing Eluting Stents Targeting the Mtor Pathway for Pulmonary Application; A Future Concept for Tracheal Stenosis.

J Mol Genet Med. 2013 Aug 26;7:65. doi: 10.4172/1747-0862.1000065.

本文引用的文献

Sirolimus-induced pulmonary hypersensitivity associated with a CD4 T-cell infiltrate.

Chest. 2006 Jun;129(6):1718-21. doi: 10.1378/chest.129.6.1718.

Hypersensitivity cases associated with drug-eluting coronary stents: a review of available cases from the Research on Adverse Drug Events and Reports (RADAR) project.

J Am Coll Cardiol. 2006 Jan 3;47(1):175-81. doi: 10.1016/j.jacc.2005.07.071. Epub 2005 Dec 1.

Late angiographic stent thrombosis (LAST) events with drug-eluting stents.

J Am Coll Cardiol. 2005 Jun 21;45(12):2088-92. doi: 10.1016/j.jacc.2005.02.086.

Paclitaxel-induced hypersensitivity pneumonitis: radiographic and CT findings.

AJR Am J Roentgenol. 2001 Mar;176(3):718-20. doi: 10.2214/ajr.176.3.1760718.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验